Latest filing published 09 Feb 2026 for Generation Bio Co..
Geoff Mcdonough (chief executive) discloses dealings in Generation Bio Co. to SEC (Form 4). The record holds 48 filings, for trades running from 16 June 2020 to 9 February 2026.
No open-market purchase appears, only 6 sales worth €898k. The rest of the record consists of 18 share grants and 18 option exercises.
Most recently, on 9 February 2026, the filings show a transaction in Generation Bio Co. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 48 declarations